Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2016 · 10-Q
Revenue$731.00K$731.00K−4.6% vs Q3 2015 Net Income-$5.38M-$5.38MN/M vs Q3 2015 EPS Diluted-$0.26-$0.26N/M vs Q3 2015 Gross Profit$113,000−57.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,637,000N/M Free Cash Flowderived-$4,642,000N/M Margins · derivedGross margin15.5%−19.0 pt vs Q3 2015
Operating margin-656.2%
Net margin-736.5%
ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end